Singapore markets close in 13 minutes
Straits Times Index
3,319.36 +11.46 (+0.35%) Nikkei
39,103.22 +486.12 (+1.26%) Hang Seng
18,868.71 -326.89 (-1.70%) FTSE 100
8,349.27 -21.06 (-0.25%) Bitcoin USD
69,590.02 -451.93 (-0.65%) CMC Crypto 200
1,517.53 +14.87 (+0.99%)
Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
| Previous close | 33.43 |
| Open | 33.69 |
| Bid | 33.30 x 0 |
| Ask | 33.31 x 0 |
| Day's range | 33.02 - 33.85 |
| 52-week range | 21.60 - 35.49 |
| Volume | |
| Avg. volume | 16,612,380 |
| Market cap | 53.253B |
| Beta (5Y monthly) | 0.04 |
| PE ratio (TTM) | 19.22 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.62 (1.76%) |
| Ex-dividend date | 15 May 2023 |
| 1y target est | N/A |
- Reuters
Merck discontinues some cancer drug development with China's Sichuan Kelun
Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development of two candidate cancer drugs which have yet to start clinical trials. Representatives for Merck did not immediately respond to a Reuters request for comment. The move comes days after Merck said it would pay Daiichi Sankyo $5.5 billion to jointly develop three of its candidate cancer drugs in a deal that could be worth up to $22 billion for the Japanese firm.
© 2024 Yahoo. All rights reserved.